home All News open_in_new Full Article

Belite Bio to Present at the dbVIC – Deutsche Bank ADR Virtual Investor Conference November 4th

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Belite Bio Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that […]


today 2 w. ago attach_file Culture

attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Other
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture


ID: 1781515187
Add Watch Country

arrow_drop_down